Related references
Note: Only part of the references are listed.A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease
Nobuya Kitaguchi et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients
Masao Kato et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Reduction of Alzheimer's Disease Amyloid-beta in Plasma by Hemodialysis and Its Relation to Cognitive Functions
N. Kitaguchi et al.
BLOOD PURIFICATION (2011)
Novel therapeutic approach for Alzheimer's disease by removing amyloid β protein from the brain with an extracorporeal removal system
Kazunori Kawaguchi et al.
JOURNAL OF ARTIFICIAL ORGANS (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
O. L. Lopez et al.
NEUROLOGY (2008)
Amyloid β 38, 40, and 42 species in cerebrospinal fluid:: more of the same?
NS Schoonenboom et al.
ANNALS OF NEUROLOGY (2005)
Selection of D-Amino-Acid peptides that bind to Alzheimer's disease amyloid peptide Aβ1-42 by mirror image phage display
K Wiesehan et al.
CHEMBIOCHEM (2003)
Intraneuronal A beta 42 accumulation in human brain
GK Gouras et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
